I5Q-MC-CGAR - ClinicalTrials.gov - NCT02797951
I5Q-MC-CGAR - ClinicalTrials.gov - NCT02797951
Key Requirements
Key Requirements
Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.
Participants must
Participant must have participated in and completed either study CGAL or study CGAM
Participant must be reliable to follow all study procedures, keep all study visits, and be compliant with study requirements - Female participant must not be pregnant or nursing
Participants must NOT
Participant must not be currently enrolled in or discontinued within the last 30 days from, a clinical trial involving any investigational drug or device (with the exception of study CGAL or study CGAM)
Trial Summary
Conditions the trial is for
Episodic Cluster Headache, Chronic Cluster Headache
What the trial is testing?
Galcanezumab (LY2951742)
Could I receive a Placebo?
no
Enrollment Goal
300
Trial Dates
July 2016 - December 2020
Trial Phase
3
Key Requirements
Use the following checklist to help determine if this trial may be a good fit for you. Place a checkmark next to each criteria that you successfully meet.
Participants must
Participant must have participated in and completed either study CGAL or study CGAM
Participant must be reliable to follow all study procedures, keep all study visits, and be compliant with study requirements - Female participant must not be pregnant or nursing
Participants must NOT
Participant must not be currently enrolled in or discontinued within the last 30 days from, a clinical trial involving any investigational drug or device (with the exception of study CGAL or study CGAM)
Trial Summary
Conditions the trial is for
Episodic Cluster Headache, Chronic Cluster Headache
What the trial is testing?
Galcanezumab (LY2951742)
Could I receive a Placebo?
no
Enrollment Goal
300
Trial Dates
July 2016 - December 2020
Trial Phase
3
Trial Locations
Hide locations not currently recruiting